Vietnam is rapidly strengthening its position as an emerging biopharmaceutical manufacturing hub, with growing investment in vaccines, biologics and biosimilars driving demand for single-use bioprocessing technologies.
Although no dedicated valuation has yet been published for Vietnam's single-use bioprocessing market, industry analysis estimates the sector is currently worth US$75–100 million in 2025 and is projected to reach US$150–210 million by 2030.
Single-use bioprocessing technologies are transforming the manufacture of biologic medicines by replacing traditional stainless-steel production systems with disposable equipment designed for one production cycle. These technologies reduce contamination risk, lower capital investment, shorten production changeovers and provide greater manufacturing flexibility—making them particularly attractive for vaccine production, biosimilars and contract manufacturing.
The market encompasses a wide range of technologies, including:
- Single-use bioreactors
- Disposable mixing systems
- Media bags and storage containers
- Filtration assemblies
- Tubing and sterile connectors
- Cell culture systems
- Downstream purification technologies
- Process sensors and sampling systems
Several structural trends are driving rapid adoption across Vietnam:
- Expansion of domestic vaccine and biologics manufacturing.
- Government policies promoting pharmaceutical self-sufficiency.
- Increasing production of biosimilars and monoclonal antibodies.
- Growth of contract development and manufacturing organisations (CDMOs).
- Rising investment in flexible, modular manufacturing facilities.
- Greater emphasis on contamination control and GMP compliance.
- Expansion of biotechnology research and pilot-scale production facilities.
Vietnam's broader biopharmaceutical sector provides a strong foundation for future growth. According to IMARC Group, the country's biopharmaceutical market reached US$1.4 billion in 2025 and is projected to grow to US$2.8 billion by 2034, supported by rising demand for biologics, biosimilars, recombinant proteins and advanced therapies.
The market is also benefiting from major investments in domestic manufacturing. In 2025, Sanofi and Vietnam Vaccine JSC (VNVC) announced construction of a vaccine manufacturing facility in Long An Province capable of producing up to 100 million vaccine doses annually from 2027. Such facilities increasingly rely on flexible single-use manufacturing platforms to accelerate production while maintaining high quality standards.
Globally, adoption of single-use technologies continues to accelerate. According to IMARC Group, the global single-use bioprocessing market reached US$21.5 billion in 2025 and is forecast to expand to US$73.6 billion by 2034. Growth is being driven by increasing biologics production, vaccine manufacturing, cell and gene therapies and wider adoption by pharmaceutical companies and CDMOs.
Innovation is further reshaping biomanufacturing. Modern single-use systems increasingly integrate automation, digital process monitoring, artificial intelligence and advanced process analytical technologies (PAT), enabling manufacturers to improve productivity, reduce contamination risks and accelerate product development. These technologies are particularly valuable for small-batch biologics, personalised medicines and rapidly scalable vaccine production.
Leading suppliers including Cytiva, Sartorius, Thermo Fisher Scientific, Merck Life Science, Danaher (Pall Corporation), Corning, Avantor, Repligen, Eppendorf and Saint-Gobain Life Sciences continue to invest in next-generation disposable bioprocessing technologies that support the global transition toward more agile and efficient biologics manufacturing.
As Vietnam continues to expand its life sciences industry and strengthen domestic biopharmaceutical production, single-use bioprocessing technologies are expected to become an essential component of future manufacturing facilities. For suppliers of bioreactors, filtration systems, disposable process equipment, automation technologies and cleanroom solutions, Vietnam represents one of Southeast Asia's most promising long-term growth opportunities.
READ THE FULL INSIGHTS REPORT
